BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19155123)

  • 1. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
    Eichelberg C; Junker K; Ljungberg B; Moch H
    Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic molecular markers in renal cell carcinoma.
    Tunuguntla HS; Jorda M
    J Urol; 2008 Jun; 179(6):2096-102. PubMed ID: 18423738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
    Sun M; Shariat SF; Cheng C; Ficarra V; Murai M; Oudard S; Pantuck AJ; Zigeuner R; Karakiewicz PI
    Eur Urol; 2011 Oct; 60(4):644-61. PubMed ID: 21741163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: basic biology and clinical behavior.
    Franklin JR; Figlin R; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
    Breda A; Konijeti R; Lam JS
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular prognostic factor in renal cell carcinoma.
    Shimazui T; Oosterwijk E; Debruyne FM; Schalken JA
    Semin Urol Oncol; 1996 Nov; 14(4):250-5. PubMed ID: 8946626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
    Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
    Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma.
    Tan KV; Namdarian B; Costello AJ; Hovens CM
    Urol Oncol; 2011; 29(3):237-43. PubMed ID: 19914100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
    Delahunt B; Bethwaite PB; Nacey JN
    Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival.
    Vasudev NS; Brown JE; Brown SR; Rafiq R; Morgan R; Patel PM; O'Donnell D; Harnden P; Rogers M; Cocks K; Anderson K; Paul A; Eardley I; Selby PJ; Banks RE
    Clin Cancer Res; 2008 Mar; 14(6):1775-81. PubMed ID: 18347179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in clear cell renal cell carcinoma.
    George S; Bukowski RM
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1737-47. PubMed ID: 18062748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
    Lam JS; Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):703s-708s. PubMed ID: 17255297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.